Morgan Stanley Maintains Overweight on Catalent, Raises Price Target to $67

Morgan Stanley maintains Catalent (NYSE:CTLT) with a Overweight and raises the price target from $64 to $67.

Benzinga · 02/04/2020 13:07

Morgan Stanley maintains Catalent (NYSE:CTLT) with a Overweight and raises the price target from $64 to $67.